Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment

BACKGROUND: In patients with non-small cell lung cancer (NSCLC), a higher response rate can be achieved with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) when selection for therapy is guided by mutation analysis or gene amplification. However, both tests are complex and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappers, I, Vollebergh, M A, van Tinteren, H, Korse, C M, Nieuwenhuis, L L, Bonfrer, J M G, Klomp, H M, van Zandwijk, N, van den Heuvel, M M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234018/
https://www.ncbi.nlm.nih.gov/pubmed/22276032
http://dx.doi.org/10.3332/ecancer.2010.178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234018/
https://www.ncbi.nlm.nih.gov/pubmed/22276032
http://dx.doi.org/10.3332/ecancer.2010.178

Ejemplares similares